🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

18,54 USD

Máx. histórico

178,74

2142 días

Split 1:6 del 12/07/2012

Caída desde máximo

-89,63%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,20%

Cierre anterior

18,32

Rango de hoy

18,29 – 18,81

Volumen hoy

1.397.929

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,44%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 10 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
20/03/1998 41,25 42,75 40,50 40,88 -1,80% 5,45% 15.550
19/03/1998 43,13 43,13 41,63 41,63 -2,63% 3,48% 4.367
18/03/1998 42,00 44,25 41,63 42,75 +1,79% 6,25% 8.467
17/03/1998 43,50 43,50 42,00 42,00 -0,88% 3,45% 4.933
16/03/1998 42,75 45,00 42,38 42,38 -0,88% 6,14% 4.283
13/03/1998 43,50 45,75 41,25 42,75 +2,70% 10,34% 13.817
12/03/1998 42,38 42,38 39,00 41,63 -0,89% 7,96% 6.233
11/03/1998 43,13 43,13 42,00 42,00 -0,44% 2,61% 2.817
10/03/1998 44,63 44,63 42,00 42,19 -3,43% 5,88% 7.450
09/03/1998 44,63 45,75 42,75 43,69 -2,10% 6,72% 11.717
06/03/1998 42,38 44,63 42,00 44,63 +4,39% 6,19% 9.733
05/03/1998 43,13 43,13 42,00 42,75 +0,00% 2,61% 7.400
04/03/1998 42,38 43,13 41,25 42,75 +1,79% 4,42% 3.050
03/03/1998 43,13 43,13 40,50 42,00 -0,88% 6,09% 6.617
02/03/1998 43,88 45,00 42,00 42,38 -3,42% 6,84% 5.283
27/02/1998 42,75 44,25 42,38 43,88 +2,63% 4,39% 8.383
26/02/1998 43,88 43,88 42,00 42,75 -1,72% 4,27% 6.067
25/02/1998 44,25 44,63 42,75 43,50 -2,52% 4,24% 1.583
24/02/1998 44,25 44,63 42,75 44,63 +0,00% 4,24% 8.500
23/02/1998 45,38 46,88 44,25 44,63 -2,86% 5,79% 7.533
20/02/1998 43,13 46,50 43,13 45,94 +5,60% 7,83% 12.533
19/02/1998 43,13 45,00 42,75 43,50 +0,00% 5,22% 11.917
18/02/1998 40,50 43,50 40,50 43,50 +7,41% 7,41% 11.800
17/02/1998 39,00 40,50 38,63 40,50 +2,86% 4,81% 12.417
13/02/1998 39,38 39,38 38,25 39,38 +0,00% 2,86% 8.517
12/02/1998 35,25 39,38 34,50 39,38 +9,38% 13,83% 10.567
11/02/1998 36,75 37,50 35,25 36,00 -4,95% 6,12% 5.450
10/02/1998 37,50 38,63 36,38 37,88 -3,81% 6,00% 5.600
09/02/1998 39,38 39,38 37,50 39,38 +0,96% 4,76% 1.517
06/02/1998 38,63 39,38 38,63 39,00 +0,00% 1,94% 2.100